PDL BioPharma Announces Departure of CFO
Since joining PDL in
"On behalf of the Company's board of directors and the management team, I'd like to thank Pete for his leadership and many contributions during his time at PDL," said
PDL's mission is to improve the lives of patients and create value for our shareholders and our people by applying our capital and expertise for the successful development and commercialization of innovative therapeutics by our partner companies. We deliver on our mission by entering into strategic transactions involving innovative late clinical-stage or early commercial-stage therapeutics with attractive revenue growth potential.
View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-announces-departure-of-cfo-300874794.html
PDL BioPharma, Inc., Peter Garcia, CFO, 775-832-8500, Peter.firstname.lastname@example.org, or LHA Investor Relations, Jody Cain, SVP, 310-691-7100, email@example.com